“…We studied 21 gene sets with prior evidence for association with neuropsychiatry, as described previously (56,57). Briefly, these gene sets were derived from the following sources: genes identified through GWAS of MDD (7), BD (8), SCZ (58), and neuroticism (59); genes identified through genetic association studies of rare variants, including exome and genome sequencing studies of SCZ (45), autism spectrum disorders (ASD) (46), or other developmental disorders(60), as well as genes intolerant to loss-of-function mutations (61); genes that are differentially expressed in the prefrontal cortex of individuals with BD, SCZ, or ASD (44); genes that have been identified as targets of the RNA binding proteins FMRP, RBFOX2, RBFOX1/3, and CELF4, of the chromatin remodeling genes CHD8, and of the microRNA miR-137 (57,62); genes localized to synapses from SynaptomeDB (63).…”